Dataset Information

Unraveling the morphological complexity of two-dimensional macromolecules.

ABSTRACT: 2D macromolecules, such as graphene and graphene oxide, possess a rich spectrum of conformational phases. However, their morphological classification has only been discussed by visual inspection, where the physics of deformation and surface contact cannot be resolved. We employ machine learning methods to address this problem by exploring samples generated by molecular simulations. Features such as metric changes, curvature, conformational anisotropy and surface contact are extracted. Unsupervised learning classifies the morphologies into the quasi-flat, folded, crumpled phases and interphases using geometrical and topological labels or the principal features of the 2D energy map. The results are fed into subsequent supervised learning for phase characterization. The performance of data-driven models is improved notably by integrating the physics of geometrical deformation and topological contact. The classification and feature extraction characterize the microstructures of their condensed phases and the molecular processes of adsorption and transport, comprehending the processing-microstructures-performance relation in applications.

SUBMITTER: Zhao Y

PROVIDER: S-EPMC9214330 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Unraveling the morphological complexity of two-dimensional macromolecules.

Zhao Yingjie Y Qin Jianshu J Wang Shijun S Xu Zhiping Z

Patterns (New York, N.Y.) 20220422 6

2D macromolecules, such as graphene and graphene oxide, possess a rich spectrum of conformational phases. However, their morphological classification has only been discussed by visual inspection, where the physics of deformation and surface contact cannot be resolved. We employ machine learning methods to address this problem by exploring samples generated by molecular simulations. Features such as metric changes, curvature, conformational anisotropy and surface contact are extracted. Unsupervis ...[more]

PMID: 35755877

Similar Datasets

Project description:BackgroundThe rising prevalence of end-stage renal failure in the elderly has led to an increased number of kidney transplantations in older individuals. While age does not solely determine transplant eligibility, frailty in elderly recipients significantly impacts post-transplant outcomes, particularly within the first year.MethodsThe RETRAITE (REnal TRAnsplantIon ouTcome in Elderly recipients) study, a single-center retrospective cohort study at Grenoble Alpes University Hospital (France), examined kidney transplant recipients aged 70 years and above transplanted between 2015 and 2020. The composite primary endpoint was defined as either of any hospital stay exceeding 40 days, death and/or return to dialysis within the first post-transplant year. The study explored risk factors for recipient and graft survival, rejection, hospitalizations over 40 days, and severe infections during the initial post-transplant year.ResultsOver six years, 149 patients aged 70 years or older received transplants. Eleven patients died, and seven returned to dialysis within the first year, corresponding to a 1-year graft survival rate of 87.9%. At 1 year, 49 patients (33%) met the composite endpoint. There was a significant association between the composite endpoint and curative anticoagulation [odds ratio (OR) 5.20; P < .001], peripheral arteriopathy (OR 3.14; P < .001) and delayed graft function (OR 8.24; P < .001). This cohort then was merged with a cohort of 150 younger kidney transplanted patients and we confirmed these results. Time on dialysis, prolonged cold ischemia and donor age contributed to higher morbidity and mortality. Conversely, preemptive and living donor transplants were associated with lower morbidity and mortality.ConclusionsIn this cohort aged over 70 years, age alone did not statistically correlate with increased morbidity and mortality. Variables related to grafts and donors, especially curative anticoagulation, were linked to poorer outcomes, emphasizing the favorable impact of preemptive and living donor transplants on morbidity and mortality in elderly patients.

Project description:Objective: The heterogeneity of amyotrophic lateral sclerosis (ALS) survival duration, which varies from <1 year to >10 years, challenges clinical decisions and trials. Utilizing data from 801 deceased ALS patients, we: (1) assess the underlying complex relationships among common clinical ALS metrics; (2) identify which clinical ALS metrics are the "best" survival predictors and how their predictive ability changes as a function of disease progression. Methods: Analyses included examination of relationships within the raw data as well as the construction of interactive survival regression and classification models (generalized linear model and random forests model). Dimensionality reduction and feature clustering enabled decomposition of clinical variable contributions. Thirty-eight metrics were utilized, including Medical Research Council (MRC) muscle scores; respiratory function, including forced vital capacity (FVC) and FVC % predicted, oxygen saturation, negative inspiratory force (NIF); the Revised ALS Functional Rating Scale (ALSFRS-R) and its activities of daily living (ADL) and respiratory sub-scores; body weight; onset type, onset age, gender, and height. Prognostic random forest models confirm the dominance of patient age-related parameters decline in classifying survival at thresholds of 30, 60, 90, and 180 days and 1, 2, 3, 4, and 5 years. Results: Collective prognostic insight derived from the overall investigation includes: multi-dimensionality of ALSFRS-R scores suggests cautious usage for survival forecasting; upper and lower extremities independently degenerate and are autonomous from respiratory decline, with the latter associating with nearer-to-death classifications; height and weight-based metrics are auxiliary predictors for farther-from-death classifications; sex and onset site (limb, bulbar) are not independent survival predictors due to age co-correlation. Conclusion: The dimensionality and fluctuating predictors of ALS survival must be considered when developing predictive models for clinical trial development or in-clinic usage. Additional independent metrics and possible revisions to current metrics, like the ALSFRS-R, are needed to capture the underlying complexity needed for population and personalized forecasting of survival.

Dataset Information

Unraveling the morphological complexity of two-dimensional macromolecules.

Publications

Unraveling the morphological complexity of two-dimensional macromolecules.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets